Ultragenyx Pharmaceutical
RARE
#4423
Rank
A$3.43 B
Marketcap
A$35.63
Share price
2.87%
Change (1 day)
-49.58%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: A$3.43 Billion

As of February 2026 Ultragenyx Pharmaceutical has a market cap of A$3.43 Billion. This makes Ultragenyx Pharmaceutical the world's 4423th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.43 B-30.19%
2025A$4.92 B-23.6%
2024A$6.44 B11.85%
2023A$5.76 B20.76%
2022A$4.77 B-39.63%
2021A$7.90 B-33.62%
2020A$11.91 B237.56%
2019A$3.52 B12.4%
2018A$3.13 B24.07%
2017A$2.53 B-36.52%
2016A$3.98 B-33.44%
2015A$5.98 B249.69%
2014A$1.71 B

End of Day market cap according to different sources

On Feb 2nd, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

A$3.43 Billion
by Nasdaq info icon info icon
A$3.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
A$0.65 B-80.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.20 B-64.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$6.45 B 87.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$16.02 B 366.05%๐Ÿ‡บ๐Ÿ‡ธ USA